Page 42 - Read Online

inhibitor VS-5584 preferentially targets cancer stem cells. Cancer cell carcinoma. Curr Treat Options Oncol 2013;14:249-63.
Res 2015;75:446-55. 110. Samimi M, Touze A. Merkel cell carcinoma: The first human
94. Eliasz S, Liang S, Chen Y, De Marco MA, Machek O, Skucha cancer shown to be associated with a polyomavirus. Presse Med
S, Miele L, Bocchetta M. Notch-1 stimulates survival of lung 2014;43:e405-11.
adenocarcinoma cells during hypoxia by activating the IGF-1R 111. Feng H, Shuda M, Chang Y, Moore PS. Clonal integration
pathway. Oncogene 2010;29:2488-98. of a polyomavirus in human Merkel cell carcinoma. Science
95. Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, 2008;319:1096-100.
Baylin SB, Ball DW. Notch signaling induces cell cycle arrest in 112. Shuda M, Feng H, Kwun HJ, Rosen ST, Gjoerup O, Moore
small cell lung cancer cells. Cancer Res 2001;61:3200-5. PS, Chang Y. T antigen mutations are a human tumor-specific
96. Zhou M, Jin WY, Fan ZW, Han RC. Analysis of the expression signature for Merkel cell polyomavirus. Proc Natl Acad Sci U S A
of the Notch3 receptor protein in adult lung cancer. Oncol Lett 2008;105:16272-7.
2013;5:499-504. 113. Shuda M, Kwun HJ, Feng H, Chang Y, Moore PS. Human Merkel
97. Ito T, Udaka N, Yazawa T, Okudela K, Hayashi H, Sudo T, Guillemot cell polyomavirus small T antigen is an oncoprotein targeting the
F, Kageyama R, Kitamura H. Basic helix-loop-helix transcription 4E-BP1 translation regulator. J Clin Invest 2011;121:3623-34.
factors regulate the neuroendocrine differentiation of fetal mouse 114. Goh G, Walradt T, Markarov V, Blom A, Riaz N, Doumani R,
pulmonary epithelium. Development 2000;127:3913-21. Stafstrom K, Moshiri A, Yelistratova L, Levinsohn J, Chan TA,
98. Morimoto M, Nishinakamura R, Saga Y, Kopan R. Different Nghiem P, Lifton RP, Choi J. Mutational landscape of MCPyV-
assemblies of Notch receptors coordinate the distribution of positive and MCPyV-negative Merkel cell carcinomas with
the major bronchial Clara, ciliated and neuroendocrine cells. implications for immunotherapy. Oncotarget 2016;7:3403-15.
Development 2012;139:4365-73. 115. Harms PW, Vats P, Verhaegen ME, Robinson DR, Wu YM,
99. Yen WC, Fischer MM, Axelrod F, Bond C, Cain J, Cancilla B, Dhanasekaran SM, Palanisamy N, Siddiqui J, Cao X, Su F, Wang
Henner WR, Meisner R, Sato A, Shah J, Tang T, Wallace B, Wang R, Xiao H, Kunju LP, Mehra R, Tomlins SA, Fullen DR, Bichakjian
M, Zhang C, Kapoun AM, Lewicki J, Gurney A, Hoey T. Targeting CK, Johnson TM, Dlugosz AA, Chinnaiyan AM. The Distinctive
Notch signaling with a Notch2/Notch3 antagonist (tarextumab) Mutational Spectra of Polyomavirus-Negative Merkel Cell
inhibits tumor growth and decreases tumor-initiating cell frequency. Carcinoma. Cancer Res 2015;75:3720-7.
Clin Cancer Res 2015;21:2084-95. 116. Lemos BD, Storer BE, Iyer JG, Phillips JL, Bichakjian CK, Fang
100. Graziani I, Eliasz S, De Marco MA, Chen Y, Pass HI, De May RM, LC, Johnson TM, Liegeois-Kwon NJ, Otley CC, Paulson KG,
Strack PR, Miele L, Bocchetta M. Opposite effects of Notch-1 and Ross MI, Yu SS, Zeitouni NC, Byrd DR, Sondak VK, Gershenwald
Notch-2 on mesothelioma cell survival under hypoxia are exerted JE, Sober AJ, Nghiem P. Pathologic nodal evaluation improves
through the Akt pathway. Cancer Res 2008;68:9678-85. prognostic accuracy in Merkel cell carcinoma: analysis of 5823
101. Yun J, Pannuti A, Espinoza I, Zhu H, Hicks C, Zhu X, Caskey cases as the basis of the first consensus staging system. J Am Acad
M, Rizzo P, D’Souza G, Backus K, Denning MF, Coon J, Sun M, Dermatol 2010;63:751-61.
Bresnick EH, Osipo C, Wu J, Strack PR, Tonetti DA, Miele L. 117. Lemos B, Nghiem P. Merkel cell carcinoma: more deaths but still no
Crosstalk between PKCalpha and Notch-4 in endocrine-resistant pathway to blame. J Invest Dermatol 2007;127:2100-3.
breast cancer cells. Oncogenesis 2013;2:e60. 118. Mauzo SH, Ferrarotto R, Bell D, Torres-Cabala CA, Tetzlaff MT,
102. Parr C, Watkins G, Jiang WG. The possible correlation of Notch-1 Prieto VG, Aung PP. Molecular characteristics and potential therapeutic
and Notch-2 with clinical outcome and tumour clinicopathological targets in Merkel cell carcinoma. J Clin Pathol 2016;69:382-90.
parameters in human breast cancer. Int J Mol Med 2004;14:779-86. 119. Iyer JG, Parvathaneni U, Gooley T, Miller NJ, Markowitz E, Blom
103. Sun J, Deng WM. Notch-dependent downregulation of the A, Lewis CW, Doumani RF, Parvathaneni K, Anderson A, Bestick
homeodomain gene cut is required for the mitotic cycle/endocycle A, Liao J, Kane G, Bhatia S, Paulson K, Nghiem P. Single-fraction
switch and cell differentiation in Drosophila follicle cells. Development radiation therapy in patients with metastatic Merkel cell carcinoma.
2005;132:4299-308. Cancer Med 2015;4:1161-70.
104. Osipo C, Golde TE, Osborne BA, Miele LA. Off the beaten 120. Lebbe C, Becker JC, Grob JJ, Malvehy J, Del Marmol V,
pathway: the complex cross talk between Notch and NF-kappaB. Pehamberger H, Peris K, Saiag P, Middleton MR, Bastholt L, Testori
Lab Invest 2008;88:11-7. A, Stratigos A, Garbe C, European Dermatology Forum tEAoD-O,
105. Raafat A, Lawson S, Bargo S, Klauzinska M, Strizzi L, Goldhar AS, the European Organization for R, Treatment of C. Diagnosis and
Buono K, Salomon D, Vonderhaar BK, Callahan R. Rbpj conditional treatment of Merkel Cell Carcinoma. European consensus-based
knockout reveals distinct functions of Notch4/Int3 in mammary interdisciplinary guideline. Eur J Cancer 2015;51:2396-403.
gland development and tumorigenesis. Oncogene 2009;28:219-30. 121. Poulsen M, Rischin D, Walpole E, Harvey J, Mackintosh J, Ainslie
106. Robinson DR, Kalyana-Sundaram S, Wu YM, Shankar S, Cao X, J, Hamilton C, Keller J, Tripcony L, Trans-Tasman Radiation
Ateeq B, Asangani IA, Iyer M, Maher CA, Grasso CS, Lonigro Oncology G. High-risk Merkel cell carcinoma of the skin treated
RJ, Quist M, Siddiqui J, Mehra R, Jing X, Giordano TJ, Sabel with synchronous carboplatin/etoposide and radiation: a Trans-
MS, Kleer CG, Palanisamy N, Natrajan R, Lambros MB, Reis- Tasman Radiation Oncology Group Study -- TROG 96:07. J Clin
Filho JS, Kumar-Sinha C, Chinnaiyan AM. Functionally recurrent Oncol 2003;21:4371-6.
rearrangements of the MAST kinase and Notch gene families in 122. Tai PT, Yu E, Winquist E, Hammond A, Stitt L, Tonita J, Gilchrist J.
breast cancer. Nat Med 2011;17:1646-51. Chemotherapy in neuroendocrine/Merkel cell carcinoma of the skin:
107. Heath M, Jaimes N, Lemos B, Mostaghimi A, Wang LC, Penas case series and review of 204 cases. J Clin Oncol 2000;18:2493-9.
PF, Nghiem P. Clinical characteristics of Merkel cell carcinoma at 123. Fakiha M, Letertre P, Vuillez JP, Lebeau J. Remission of Merkel
diagnosis in 195 patients: the AEIOU features. J Am Acad Dermatol cell tumor after somatostatin analog treatment. J Cancer Res Ther
2008;58:375-81. 2010;6:382-4.
108. Albores-Saavedra J, Batich K, Chable-Montero F, Sagy N, 124. Gardair C, Samimi M, Touze A, Coursaget P, Lorette G, Caille A,
Schwartz AM, Henson DE. Merkel cell carcinoma demographics, Wierzbicka E, Croue A, Avenel-Audran M, Aubin F, Kerdraon R,
morphology, and survival based on 3870 cases: a population based Esteve E, Beneton N, Guyetant S. Somatostatin receptors 2A and
study. J Cutan Pathol 2010;37:20-7. 5 are expressed in Merkel cell carcinoma with no association with
109. Miller NJ, Bhatia S, Parvathaneni U, Iyer JG, Nghiem P. Emerging disease severity. Neuroendocrinology 2015;101:223-35.
and mechanism-based therapies for recurrent or metastatic Merkel 125. Davids MS, Charlton A, Ng SS, Chong ML, Laubscher K, Dar M,
Journal of Cancer Metastasis and Treatment ¦ Volume 2 ¦ August 17, 2016 ¦ 291